FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

NAVNETEDUL Share Price Discussion

Navneet Education Ltd.
Sector: Paper
... Read more
NAVNETEDUL Share Price *
89.5 -0.5 (-0.56%)
* (quote may be delayed)

Find answers to all your questions on live NAVNETEDUL message board: Is NAVNETEDUL buy or sell? Should I buy NAVNETEDUL shares? Why are NAVNETEDUL shares falling? Should I invest in NAVNETEDUL stock?


You can also check NAVNETEDUL share price target recommended by brokerages.

NAVNETEDUL Discussion Forum


Prabhudas Lilladher target on NAVNETEDUL
Date: 14-Nov-19 Broker: Prabhudas Lilladher Price @ Call: 98.67 Target: 142 Recommendation: BUY
Like
reply
Reply
share
Share
Natco Pharma gets EIR from USFDA for Hyderabad facility
In a BSE filing, Natco Pharma announced "successful closure of inspection" with the receipt of an establishment inspection report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its active pharmaceutical ingredient (API) facility in Mekaguda Village, near Hyderabad, India.
Moneycontrol
Like
reply
Reply
share
Share
Buy Navneet Education; target of Rs 130: ICICI Direct
ICICI Direct is bullish on Navneet Education has recommended buy rating on the stock with a target price of Rs 130 in its research report dated August 12, 2019.
moneycontrol.com
Like
reply
Reply
share
Share
Hold Natco Pharma; target of Rs 595: ICICI Direct
ICICI Direct recommended hold rating on Natco Pharma with a target price of Rs 595 in its research report dated August 12, 2019.
moneycontrol.com
Like
reply
Reply
share
Share
Buy Navneet Education; target of Rs 134: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Navneet Education has recommended buy rating on the stock with a target price of Rs 134 in its research report date August 09, 2019.
moneycontrol.com
Like
reply
Reply
share
Share
Natco Pharma Consolidated June 2019 Net Sales at Rs 492.30 crore, down 8.6% Y-o-Y
moneycontrol.com
Like
reply
Reply
share
Share
Natco Pharma Standalone June 2019 Net Sales at Rs 464.70 crore, down 9.89% Y-o-Y
moneycontrol.com
Like
reply
Reply
share
Share
Natco Pharma gets EIR from USFDA for Kothur facility
The receipt of EIR from the United States Food and Drug Administration (USFDA) indicates the successful closure of inspection of the company’s drug formulations facility in Kothur, Natco Pharma said in a BSE filing.
moneycontrol.com
Like
reply
Reply
share
Share
Stocks in the news: ICICI Bank, Cadila Health, Mahindra Life, Vedanta, Uflex, Granules, NHPC
Maruti Suzuki | Allahabad Bank | Future Lifestyle Fashions | ICICI Bank | Power Mech Projects | Manpasand Beverages and Usha Martin are stocks which are in news today.
www.moneycontrol.com
Like
reply
Reply
share
Share
Stocks in the news: ICICI Bank, Cadila Health, Mahindra Life, Vedanta, Uflex, Granules India
Maruti Suzuki | Allahabad Bank | Future Lifestyle Fashions | ICICI Bank | Power Mech Projects | Manpasand Beverages and Usha Martin are stocks which are in news today.
www.moneycontrol.com
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
  • NAVNETEDUL - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization3,322.25
    Enterprise Value3,527.68
    Price to Earnings21.71
    Price to Book Value4.12
    Return on Capital Employed0.24
    Return on Equity0.19
    Face Value2
    Dividend Yield0.01
  • NAVNETEDUL Share Price - Technicals

    keyboard_arrow_down
    NAVNETEDUL - 52 Week High₹119.95
    NAVNETEDUL - 52 Week Low₹88.5
  • NAVNETEDUL - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    14-Nov-19Prabhudas LilladherBuy142
    9-Aug-19Prabhudas LilladherBuy134
    21-May-19ICICIdirect.comBuy130
    20-May-19Motilal OswalBuy135
    16-May-19Prabhudas LilladherBuy142
    NAVNETEDUL Brokerage Price Target
  • NAVNETEDUL Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Dec 1289.0592.958990
    Dec 1190.591.7588.589.75
    Dec 1092.9592.9590.190.3
    Dec 993.3593.491.7592.1
    Dec 694.8594.8593.0593.3
  • NAVNETEDUL Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹96.81
    30 Day Moving Average₹97.84
    50 Day Moving Average₹99.64
    100 Day Moving Average₹100.81
    200 Day Moving Average₹104.56
  • NAVNETEDUL - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,1311,093.750.03
    Operating Profit236259.41-0.09
    Profit Before Tax234245.98-0.05
    Net Income153161.63-0.05
  • NAVNETEDUL - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds807725.60.11
    Total Liabilities331268.870.23
    Total Assets1,141994.470.15
  • NAVNETEDUL - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity5893.63-0.38
    Cash from Investing Activity-46-1.5528.68
    Cash from Financing Activity-77-102.41-0.25
    Net Cash Flow-65-10.335.29
  • NAVNETEDUL - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.130.16
    Return on Equity0.190.22
    Return on Capital Employed0.240.29
  • NAVNETEDUL - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.18
    3 Year CAGR Growth in Operating Profit0.06
    3 Year CAGR Growth in EBIDTA0.11
    3 Year CAGR Growth in Net Income0.18
    3 Yr CAGR Growth - Diluted EPS0.21
  • NAVNETEDUL - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.43
    5 Year CAGR Growth in Operating Profit0.3
    5 Year CAGR Growth in EBIDTA0.34
    5 Year CAGR Growth in Net Income0.38
    3 Yr CAGR Growth - Diluted EPS0.41
  • NAVNETEDUL - Recent News

    keyboard_arrow_down
    NewsBot
    Oct 1 4:23 PM
    Natco Pharma gets EIR from USFDA for Hyderabad facility
    Moneycontrol
    NewsBot
    Aug 13 9:18 PM
    Buy Navneet Education; target of Rs 130: ICICI Direct
    moneycontrol.com
    NewsBot
    Aug 13 6:43 PM
    Hold Natco Pharma; target of Rs 595: ICICI Direct
    moneycontrol.com
    NewsBot
    Aug 12 9:08 PM
    Buy Navneet Education; target of Rs 134: Prabhudas Lilladher
    moneycontrol.com
    NewsBot
    Aug 9 9:13 PM
    Natco Pharma Consolidated June 2019 Net Sales at Rs 492.30 crore, down 8.6% Y-o-Y
    moneycontrol.com
    NewsBot
    Aug 9 9:13 PM
    Natco Pharma Standalone June 2019 Net Sales at Rs 464.70 crore, down 9.89% Y-o-Y
    moneycontrol.com
    NewsBot
    Aug 5 7:18 PM
    Natco Pharma gets EIR from USFDA for Kothur facility
    moneycontrol.com
    NewsBot
    Jul 29 2:13 PM
    Stocks in the news: ICICI Bank, Cadila Health, Mahindra Life, Vedanta, Uflex, Granules, NHPC
    www.moneycontrol.com
    NewsBot
    Jul 29 1:18 PM
    Stocks in the news: ICICI Bank, Cadila Health, Mahindra Life, Vedanta, Uflex, Granules India
    www.moneycontrol.com
    NewsBot
    Jul 18 7:33 PM
  • NAVNETEDUL - Related Communities

    keyboard_arrow_down
    Antarctica Ltd. Sector: Paper
    TCPL Packaging Ltd. Sector: Paper
    Sundaram Multi Pap Ltd. Sector: Paper
    Sandesh Ltd. Sector: Paper
    Sambhaav Media Ltd. Sector: Paper
    Repro India Ltd. Sector: Paper
    Orient Press Ltd. Sector: Paper
    Navneet Education Ltd. Sector: Paper
    MPS Ltd. Sector: Paper
    Linc Pen & Plastics Ltd. Sector: Paper
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.